XOMA Royalty (XOMA) FCF Margin Growth (1y) (2012 - 2026)
XOMA Royalty (XOMA) FCF Margin Growth (1y) (2012 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
5,389.00 |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
1,525.00 |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
XOMA Royalty |
5.52 Mn |
-60.56 Mn |
- |
-526.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
-526.00 |
| Dec 31, 2025 |
56,838.00 |
| Sep 30, 2025 |
3.44 Mn |
| Jun 30, 2025 |
7,449.00 |
| Mar 31, 2025 |
38,810.00 |
| Dec 31, 2024 |
-36,696.00 |
| Sep 30, 2024 |
-3.42 Mn |
| Jun 30, 2024 |
110,194.00 |
| Mar 31, 2024 |
79,362.00 |
| Dec 31, 2023 |
4,754.00 |
| Sep 30, 2023 |
55,930.00 |
| Jun 30, 2023 |
-60,851.00 |
| Mar 31, 2023 |
-109,430.00 |
| Dec 31, 2022 |
-1.56 Mn |
| Sep 30, 2022 |
-48,507.00 |
| Jun 30, 2022 |
201.00 |
| Mar 31, 2022 |
21,126.00 |
| Dec 31, 2021 |
1.53 Mn |
| Sep 30, 2021 |
11,022.00 |
| Jun 30, 2021 |
20,522.00 |
